St. Olav's University Hospital is the hospital in Trondheim, Norway located at Øya. It is part of St. Olavs Hospital Trust that operates all the hospitals in Sør-Trøndelag and thus indirectly state owned.

During the past decade, Kreftklinikken, St Olavs Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kreftklinikken, St Olavs Hospital" #1 collaborator was "Alesund Hospital" with 1 trials as a collaborator, "Asker & Baerum Hospital" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator and "Helse Nord-Trøndelag HF" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kreftklinikken, St Olavs Hospital" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "DLBCL" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials) and "MCL" (1 trials). Many other conditions were trialed in "Kreftklinikken, St Olavs Hospital" in a lesser frequency.

Most popular intervention types in "Kreftklinikken, St Olavs Hospital" are "Drug" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "5-Fluorouracil (5FU)" (1 trials), "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials) and "Aromatase Inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kreftklinikken, St Olavs Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Kreftklinikken, St Olavs Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kreftklinikken, St Olavs Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kreftklinikken, St Olavs Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".